Showing 1 - 14 results of 14 for search 'Gloria Taliani', query time: 0.06s
Refine Results
-
1
-
2
-
3
Precision Medicine: Determination of Ribavirin Urinary Metabolites in Relation to Drug Adverse Effects in HCV Patients by Ottavia Giampaoli, Fabio Sciubba, Elisa Biliotti, Mariangela Spagnoli, Riccardo Calvani, Alberta Tomassini, Giorgio Capuani, Alfredo Miccheli, Gloria Taliani
Published 2022-09-01
Article -
4
-
5
IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection. by Gloria Taliani, Martina Spaziante, Elisa Biliotti, Marina Borro, Donatella Palazzo, Stefania Grieco, Cristiana Franchi, Giancarlo Iaiani, Caterina Furlan, Valentina Gallinaro, Maurizio Simmaco
Published 2013-01-01
Article -
6
Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization by Lucia Fontanelli Sulekova, Simona Gabrielli, Federica Furzi, Giovanni Luigi Milardi, Elisa Biliotti, Maurizio De Angelis, Giancarlo Iaiani, Caterina Fimiani, Myriam Maiorano, Simonetta Mattiucci, Gloria Taliani
Published 2019-10-01
Article -
7
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study by Martina Spaziante, Gloria Taliani, Giulia Marchetti, Alessandro Tavelli, Miriam Lichtner, Antonella Cingolani, Stefania Cicalini, Elisa Biliotti, Enrico Girardi, Andrea Antinori, Massimo Puoti, Antonella d’Arminio Monforte, Alessandro Cozzi-Lepri
Published 2021-07-01
Article -
8
Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. by Marco Falcone, Alessandro Russo, Maddalena Giannella, Roberto Cangemi, Maria Gabriella Scarpellini, Giuliano Bertazzoni, José Martínez Alarcón, Gloria Taliani, Paolo Palange, Alessio Farcomeni, Annarita Vestri, Emilio Bouza, Francesco Violi, Mario Venditti
Published 2015-01-01
Article -
9
Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study by Daniela Aschieri, Marco Stabile, Cristina Maestri, Luca Rosato, Michela Giovanna Coccia, Paola Novara, Gianluca Lanati, Maria Teresa Di Dio, Cosimo Franco, Giuseppina Bisceglie, Giuseppe Leddi, Enrico Fabrizi, Paola Rucci, Gloria Taliani
Published 2021-09-01
Article -
10
Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy by Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti
Published 2021-11-01
Article -
11
Treatment for COVID-19—a cohort study from Northern Italy by Lorenzo Guglielmetti, Daniela Aschieri, Irina Kontsevaya, Francesco Calabrese, Alessandra Donisi, Alberto Faggi, Patrizia Ferrante, Elisa Fronti, Laura Gerna, Maria Cristina Leoni, Franco Paolillo, Giovanna Ratti, Alessandro Ruggieri, Daria Sacchini, Marta Scotti, Caterina Valdatta, Marco Stabile, Gloria Taliani, Mauro Codeluppi
Published 2021-10-01
Article -
12
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study by Simone Lanini, Paola Scognamiglio, Alessandra Mecozzi, Lorella Lombardozzi, Vincenzo Vullo, Mario Angelico, Antonio Gasbarrini, Gloria Taliani, Adolfo Francesco Attili, Carlo Federico Perno, Adriano De Santis, Vincenzo Puro, Fabio Cerqua, Gianpiero D’Offizi, Adriano Pellicelli, Orlando Armignacco, Francesco Saverio Mennini, Massimo Siciliano, Enrico Girardi, Vincenzo Panella, Giuseppe Ippolito, members of the Lazio Region HCV treatment group
Published 2018-05-01
Article -
13
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. by Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, Laura Ambra Nicolini, Andrea Antinori, Laura Milazzo, Salvatore Sollima, Guido Gubertini, Fosca Niero, Annalisa Saracino, Raffaele Bruno, Vanni Borghi, Francesca Montagnani, Annamaria Cattelan, Hamid Hasson, Gloria Taliani, Antonella D'Arminio Monforte, Claudio Mastroianni, Giovanni Di Perri, Sara Bigoni, Massimo Puoti, Angiola Spinetti, Andrea Gori, Nicola Boffa, Bruno Cacopardo, Andrea Giacometti, Giustino Parruti, Vincenzo Vullo, Antonio Chirianni, Elisabetta Teti, Caterina Pasquazzi, Daniela Segala, Massimo Andreoni
Published 2018-01-01
Article -
14
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. by Valeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, Elisa Biliotti, Laura Gianserra, Ilaria Lenci, Daniele Di Paolo, Vincenza Calvaruso, Elisabetta Teti, Maddalena Cerrone, Dante Romagnoli, Michela Melis, Elena Danieli, Barbara Menzaghi, Ennio Polilli, Massimo Siciliano, Laura Ambra Nicolini, Antonio Di Biagio, Carlo Federico Magni, Matteo Bolis, Francesco Paolo Antonucci, Velia Chiara Di Maio, Roberta Alfieri, Loredana Sarmati, Paolo Casalino, Sergio Bernardini, Valeria Micheli, Giuliano Rizzardini, Giustino Parruti, Tiziana Quirino, Massimo Puoti, Sergio Babudieri, Antonella D'Arminio Monforte, Massimo Andreoni, Antonio Craxì, Mario Angelico, Caterina Pasquazzi, Gloria Taliani, Jeremie Guedj, Carlo Federico Perno, Francesca Ceccherini-Silberstein
Published 2017-01-01
Article